ES8705043A1 - Transmissible, mammalian genes associated with tumor metastasis. - Google Patents
Transmissible, mammalian genes associated with tumor metastasis.Info
- Publication number
- ES8705043A1 ES8705043A1 ES549438A ES549438A ES8705043A1 ES 8705043 A1 ES8705043 A1 ES 8705043A1 ES 549438 A ES549438 A ES 549438A ES 549438 A ES549438 A ES 549438A ES 8705043 A1 ES8705043 A1 ES 8705043A1
- Authority
- ES
- Spain
- Prior art keywords
- transmissible
- tumor metastasis
- genes associated
- mammalian genes
- metastasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Abstract
A method for detecting a discrete, transmissible, mammalian gene associated with tumor metastasis. Using the method, a gene associated with metastasis and originating in the human cervical carcinoma line ME-180, metastatic to omentum, and a gene associated with metastasis and originating in the human neuroblastoma cell line SK-N-MC, metastatic to the supraorbital area, have been detected and identified.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67662584A | 1984-11-30 | 1984-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES549438A0 ES549438A0 (en) | 1987-04-16 |
ES8705043A1 true ES8705043A1 (en) | 1987-04-16 |
Family
ID=24715276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES549438A Expired ES8705043A1 (en) | 1984-11-30 | 1985-11-29 | Transmissible, mammalian genes associated with tumor metastasis. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0203970A1 (en) |
JP (1) | JPS62501399A (en) |
AU (1) | AU5197986A (en) |
DK (1) | DK359486D0 (en) |
ES (1) | ES8705043A1 (en) |
FI (1) | FI863095L (en) |
GR (1) | GR852864B (en) |
HU (1) | HUT41837A (en) |
IL (1) | IL77157A0 (en) |
NO (1) | NO863066L (en) |
PT (1) | PT81584B (en) |
WO (1) | WO1986003226A1 (en) |
ZA (1) | ZA859070B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049662A (en) * | 1987-10-13 | 1991-09-17 | The United States Of America As Represented By The Department Of Health And Human Services | Kit for diagnosing cancer metastatic potential |
ES2164634T3 (en) * | 1989-10-18 | 2002-03-01 | Us Health | PRODUCTION AND USE OF HUMAN NM23-H2 PROTEIN AND ANTIBODIES INTENDED TO SUCH EFFECT. |
US6825320B1 (en) | 1995-03-29 | 2004-11-30 | Millenium Pharmaceuticals, Inc. | FOHY03 polypeptides |
US6794185B1 (en) | 1995-03-29 | 2004-09-21 | Millennium Pharmaceuticals, Inc. | fohy030 nucleic acid molecules |
US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
US6251597B1 (en) | 1996-03-29 | 2001-06-26 | Millennium Pharmaceuticals, Inc. | Methods for detecting fohy030 |
ATE250673T1 (en) * | 1995-11-16 | 2003-10-15 | Baylor College Medicine | METHOD FOR IDENTIFYING METASTATIC SEQUENCES |
USRE38490E1 (en) | 1995-11-16 | 2004-04-06 | Baylor College Of Medicine | Method for identifying metastatic sequences |
US5783182A (en) * | 1996-01-30 | 1998-07-21 | Baylor College Of Medicine | Method for identifying metastatic sequences |
EP0873424B1 (en) * | 1996-01-10 | 2004-08-25 | The University Of Liverpool | Metastasis inducing dna's |
USRE38392E1 (en) | 1996-01-30 | 2004-01-20 | Baylor College Of Medicine | Method for identifying metastatic sequences |
US6312909B1 (en) | 1996-03-29 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis prevention and treatment of tumor progression |
US6252058B1 (en) | 1997-11-05 | 2001-06-26 | Timothy C. Thompson | Sequences for targeting metastatic cells |
CA2323074A1 (en) | 1998-03-13 | 1999-09-16 | Baylor College Of Medicine | Compositions and methods for the treatment and prevention of metastatic disorders |
US7462491B2 (en) | 2002-01-31 | 2008-12-09 | Baylor College Of Medicine | Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin |
-
1985
- 1985-11-26 AU AU51979/86A patent/AU5197986A/en not_active Abandoned
- 1985-11-26 HU HU8667A patent/HUT41837A/en unknown
- 1985-11-26 IL IL77157A patent/IL77157A0/en unknown
- 1985-11-26 JP JP60505382A patent/JPS62501399A/en active Pending
- 1985-11-26 EP EP85906133A patent/EP0203970A1/en not_active Withdrawn
- 1985-11-26 WO PCT/US1985/002323 patent/WO1986003226A1/en not_active Application Discontinuation
- 1985-11-27 GR GR852864A patent/GR852864B/el unknown
- 1985-11-27 ZA ZA859070A patent/ZA859070B/en unknown
- 1985-11-29 PT PT81584A patent/PT81584B/en unknown
- 1985-11-29 ES ES549438A patent/ES8705043A1/en not_active Expired
-
1986
- 1986-07-29 DK DK359486A patent/DK359486D0/en not_active Application Discontinuation
- 1986-07-29 NO NO863066A patent/NO863066L/en unknown
- 1986-07-29 FI FI863095A patent/FI863095L/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS62501399A (en) | 1987-06-11 |
FI863095A0 (en) | 1986-07-29 |
GR852864B (en) | 1986-03-28 |
DK359486A (en) | 1986-07-29 |
ZA859070B (en) | 1986-07-30 |
PT81584A (en) | 1985-12-01 |
NO863066L (en) | 1986-09-29 |
PT81584B (en) | 1987-04-07 |
HUT41837A (en) | 1987-05-28 |
DK359486D0 (en) | 1986-07-29 |
AU5197986A (en) | 1986-06-18 |
FI863095L (en) | 1986-07-29 |
NO863066D0 (en) | 1986-07-29 |
IL77157A0 (en) | 1986-04-29 |
ES549438A0 (en) | 1987-04-16 |
WO1986003226A1 (en) | 1986-06-05 |
EP0203970A1 (en) | 1986-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8705043A1 (en) | Transmissible, mammalian genes associated with tumor metastasis. | |
DE3377363D1 (en) | Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells | |
IT8583397A0 (en) | PLASTIC SHEETS FOR GREENHOUSES. | |
PT73768A (en) | Process for stabilizing and selecting host cells with recombinant dna | |
EP0131623A4 (en) | Chimeric genes suitable for expression in plant cells. | |
EP0138833A4 (en) | Cell viability assay methods and apparatus. | |
AU581264B2 (en) | Electrode for electrochemical processes,method for preparing the same and use thereof in electrolysis cells | |
IL67176A0 (en) | Method for stabilizing and selecting recombinant dna containing host cells | |
EP0125983A3 (en) | Production of butanol by fermentation in the presence of cocultures of clostridium | |
NZ211357A (en) | Recombinant dna and antigenic protein coded for | |
GB1456058A (en) | Cutting device for foamed plastics material | |
ZA859614B (en) | A monopolar electrochemical cell,cell unit,and process for conducting electrolysis in a monopolar series | |
DE3875396D1 (en) | MICRO-CARRIER MATERIAL FOR CELL CULTURE. | |
EP0203656A3 (en) | Unitary separator-spacer for electrochemical cell, and electrochemical cell construction using such spacer(s) | |
DE69316028D1 (en) | METHODS FOR DETERMINING THE NUCLEOTIDE SIZE IN DNA FRAGMENTS | |
DE3575435D1 (en) | SINTERABLE, FINE-PARTED MOLDING DIMENSIONS BASED ON VINYL CHLORIDE POLYMERISAT. | |
AU1814995A (en) | Galanin receptor, nucleic acids, transformed cells and uses thereof | |
ES509578A0 (en) | IMPROVEMENTS IN ELECTRO-DEPOSITION CELLS. | |
IL126257A0 (en) | Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer metastasis formation | |
MX9600860A (en) | Method of detecting human cytochrome p4501a2 gene polymorphism. | |
NO154310C (en) | ANODEBARING DEVICE FOR POWER SUPPLY FOR MULTIPLE ANODES IN A MELT ELECTROLYCLE CELL. | |
DE3267950D1 (en) | Membrane, electrochemical cell, and electrolysis process | |
AU579563B2 (en) | Charge-coupled device | |
ES483151A1 (en) | Method for preparing 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline and N-chloroethyl-, N-bromoethyl- or N-hydroxyethyl-2,3-dichlorobenzylamine intermediate. | |
GROLL | TECHNIQUES OF WINNING CLAY, DEVELOPMENT AND IMPORTANT FACTORS |